These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11418070)

  • 21. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy.
    Konijnenberg M; Melis M; Valkema R; Krenning E; de Jong M
    J Nucl Med; 2007 Jan; 48(1):134-42. PubMed ID: 17204710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model.
    Flynn AA; Green AJ; Boxer GM; Casey JL; Pedley RB; Begent RH
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):183-9. PubMed ID: 9989525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A voxel-based mouse for internal dose calculations using Monte Carlo simulations (MCNP).
    Bitar A; Lisbona A; Thedrez P; Sai Maurel C; Le Forestier D; Barbet J; Bardies M
    Phys Med Biol; 2007 Feb; 52(4):1013-25. PubMed ID: 17264367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy.
    Mayer R; Dillehay LE; Shao Y; Zhang YG; Song S; Bartholomew RM; Mackenson DG; Williams JR
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):147-57. PubMed ID: 7721611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W
    Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres.
    Fallahpoor M; Abbasi M; Parach AA; Kalantari F
    J Appl Clin Med Phys; 2017 Mar; 18(2):176-180. PubMed ID: 28300366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new method for determining dose rate distribution from radioimmuno-therapy using radiochromic media.
    Mayer R; Dillehay LE; Shao Y; Song S; Zhang YG; Bartholomew RM; Williams JR
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):505-13. PubMed ID: 8276668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity.
    Sparks RB; Crowe EA; Wong FC; Toohey RE; Siegel JA
    J Nucl Med; 2002 Aug; 43(8):1110-4. PubMed ID: 12163638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S; Trisler K; Wessels BW; Knox SJ
    Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A method for patient-specific absorbed dose estimation for internal beta emitters.
    Williams LE; Liu A; Raubitschek AA; Wong JY
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3015s-3019s. PubMed ID: 10541337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Realistic Multiregion Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy.
    Vargas CS; Struelens L; D'Huyvetter M; Caveliers V; Covens P
    J Nucl Med; 2023 Mar; 64(3):493-499. PubMed ID: 36229185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney.
    Bouchet LG; Bolch WE; Blanco HP; Wessels BW; Siegel JA; Rajon DA; Clairand I; Sgouros G
    J Nucl Med; 2003 Jul; 44(7):1113-47. PubMed ID: 12843230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosensitivity of colorectal cancer to
    Lee BQ; Abbott EM; Able S; Thompson JM; Hill MA; Kartsonaki C; Vallis KA; Falzone N
    Phys Med Biol; 2019 Jul; 64(13):135018. PubMed ID: 31117062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of lipid-soluble complexes in targeted tumor therapy.
    Thakur ML; Coss R; Howell R; Vassileva-Belnikolovska D; Liu J; Rao SP; Spana G; Wachsberger P; Leeper DL
    J Nucl Med; 2003 Aug; 44(8):1293-300. PubMed ID: 12902421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monte Carlo simulation of radiation transport and dose deposition from locally released gold nanoparticles labeled with
    Lai P; Cai Z; Pignol JP; Lechtman E; Mashouf S; Lu Y; Winnik MA; Jaffray DA; Reilly RM
    Phys Med Biol; 2017 Oct; 62(22):8581-8599. PubMed ID: 29077574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
    Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
    J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.
    Palm S; Enmon RM; Matei C; Kolbert KS; Xu S; Zanzonico PB; Finn RL; Koutcher JA; Larson SM; Sgouros G
    J Nucl Med; 2003 Jul; 44(7):1148-55. PubMed ID: 12843231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.